Avaliação da trombocitopenia

Última revisão: 2 Dec 2025
Última atualização: 22 Oct 2025

Resumo

Diagnósticos diferenciais

comuns

  • Leucemia
  • Neoplasia metastática
  • Linfoma de Hodgkin
  • Linfoma não Hodgkin
  • Tuberculose miliar
  • Coagulação intravascular disseminada (CIVD)
  • Pós-transfusão
  • Hemólise, enzimas hepáticas elevadas, plaquetopenia (HELLP)
  • Derivação cardiopulmonar
  • Trombocitopenia imune (ITP)
  • Lúpus eritematoso sistêmico (LES)
  • Artrite reumatoide
  • Síndrome antifosfolipídica
  • Vírus da imunodeficiência humana (HIV)/síndrome de imunodeficiência adquirida (AIDS)
  • Malária
  • Febre da dengue
  • Infecção pelo vírus da Zika
  • Citomegalovírus (CMV)
  • Mononucleose infecciosa
  • COVID-19
  • Parvovírus B19
  • Sepse
  • Trombocitopenia induzida por heparina (TIH)
  • Medicamentos antimaláricos, antiepilépticos, antibióticos ou quimioterápicos
  • Ingestão de bebidas alcoólicas
  • Deficiência de B12
  • Deficiência de folato
  • Trombocitopenia gestacional
  • Cirrose
Detalhes completos

Incomuns

  • Mieloma múltiplo
  • Fibrose da medula óssea
  • Púrpura trombocitopênica trombótica (PTT)
  • Síndrome hemolítico-urêmica (SHU)
  • Sarcoidose
  • Trombocitopenia cíclica
  • Síndrome de Wiskott-Aldrich
  • Distúrbios relacionados a MYH9, incluindo anomalia de May-Hegglin
  • Síndrome de Bernard-Soulier
  • Doença de Gaucher
  • Tireoidite de Hashimoto
  • Anemia aplásica
  • Vacinações
  • Hemoglobinúria paroxística noturna (HPN)
  • Pseudotrombocitopenia
  • Distúrbio plaquetário hereditário com mutação em RUNX1 na linha germinativa.
  • Trombocitopenia por mutação da linha germinativa em ANKRD26
  • Trombocitopenia devido a mutação germinativa em ETV6
Detalhes completos

Colaboradores

Autores

Hanny Al-Samkari, MD

Division of Hematology/Oncology

Peggy S. Blitz Endowed Chair in Hematology/Oncology

Massachusetts General Hospital

Associate Professor of Medicine

Harvard Medical School

Boston

MA

Declarações

HA has received fees for consulting from Agios, Amgen, argenx, Alpine, Alnylam, Sobi, Pharmacosmos, Novartis and Sanofi; and received research funding to their institution from Amgen, Agios, Sobi, Novartis, and Vaderis.

Agradecimentos

Dr Hanny Al-Samkari would like to gratefully acknowledge Dr Julia T. Geyer and Dr Alan E. Lichtin, previous contributors to this topic. JTG declares that she has no competing interests. AEL is on an advisory board and has received research support from Amgen.

Revisores

Roger M. Lyons, MD, FACP

Clinical Professor of Medicine

University of Texas Health Science Center

San Antonio

Cancer Care Network of South Texas

San Antonio

TX

Declarações

RML declares that he has no competing interests.

Jeffrey S. Wasser, MD

Clinical Assistant Professor of Medicine

University of Connecticut School of Medicine

Farmington

CT

Disclosures

JSW has received research support from Amgen, Ligand Pharmaceuticals, and MGI Pharma for clinical studies in immune thrombocytopenic purpura.

Keith R. McCrae, MD

Professor of Medicine

Case Western Reserve University School of Medicine

Cleveland

OH

Disclosures

KRM declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3(22):3780-817.Full text  Abstract

Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017 Nov 23;130(21):2271-7.Full text  Abstract

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 207: thrombocytopenia in pregnancy. Obstet Gynecol. 2019 Mar;133(3):e181-93. Abstract

Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019 Sep 5;381(10):945-55.Full text  Abstract

Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Avaliação da trombocitopenia images
  • Guidelines

    • A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies
    • Practice bulletin no. 207: thrombocytopenia in pregnancy
    More Guidelines
  • Patient information

    Linfoma não Hodgkin

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer